Methods using administration of medium chain triglycerides (MCT) prior to a meal to increase ketone production from the MCTs

A method of treating a condition for which increased production of ketones from medium chain triglycerides (MCTs) is beneficial, wherein the condition is a neurological condition or a brain energy deficiency condition selected from the group consisting of a migraine, a memory disorder, an age-related memory disorder, a brain injury, a stroke, amyotrophic lateral sclerosis, multiple sclerosis, cognitive impairment, cognitive impairment post-intensive care, age-induced cognition impairment, Alzheimer's disease, Parkinson's disease, Huntington's disease, an inherited metabolic disorder, bipolar disorder, schizophrenia, epilepsy, and combinations thereof, the method comprising:

• orally administering, to an individual having the condition or at risk of the condition, a composition comprising the MCTs in a serving or unit dosage form that provides a therapeutically effective amount of the MCTs and/or provides an amount of the MCTs metabolized into a therapeutically effective amount of ketones;
• wherein a meal is administered at least about fifteen minutes after the orally administering the composition comprising the MCTs and within about forty minutes after the orally administering the composition comprising the MCTs;
• and
• wherein the composition is administered to the individual in a serving comprising about 15.0 g of the MCTs and the composition comprises the MCTs emulsified in at least one additional component selected from the group consisting of a protein, a lipid, a carbohydrate, and an emulsifier.

A method of improving or maintaining at least one of neurologic health, cognitive function, or exercise performance in an individual in need thereof, the method comprising:

• orally administering to the individual a composition comprising medium chain triglycerides (MCTs);
• and
• wherein a meal is administered at least about fifteen minutes after the orally administering the composition comprising the MCTs and within about forty minutes after the orally administering the composition comprising the MCTs;
• wherein the composition is administered to the individual in a serving comprising about 15.0 g of the MCTs and the composition comprises the MCTs emulsified in at least one additional component selected from the group consisting of a protein, a lipid, a carbohydrate, and an emulsifier.